Researchers Engineered 3D Model for Recurrent UTIs
The micro-bladder model enables testing of combination therapies to address antibiotic-resistant bacterial infections.
Updated on Sept. 22, 2026 in Life Sciences
Live Poll
Should medical researchers prioritize complex human-relevant models over static lab tests for drug efficacy?
Researchers have developed a 3D micro-bladder model that simulates human conditions by incorporating flowing urine to study recurrent urinary tract infections. This research-stage tool aims to overcome limitations in standard lab tests that fail to replicate the complex urinary environment.
Why it matters
Intracellular bacterial communities often hide from standard antibiotics, contributing to a global burden of 260,000 deaths associated with antimicrobial resistance in urinary tract infections in 2019. This model allows for the investigation of new treatments, such as combination phage and antibiotic therapy, to reach infections hidden within the bladder wall.
The 3D model replicates bladder conditions by using flowing urine, which causes uropathogenic Escherichia coli to change from a rod shape into long filaments. While traditional antibiotics failed to clear the infections in this system, the model demonstrated that combined phage and antibiotic therapy successfully eliminated bacteria.
The players
University College London
A public research university that maintains extensive programs in medical sciences and advanced biomedical engineering.
The details
The model uses flow dynamics to mimic the human bladder, allowing researchers to study how bacteria form intracellular communities—clusters of pathogens that reside within host cells. Phage therapy—the use of viruses that specifically infect and kill bacteria—was found to induce signals that attract white blood cells to the bladder lumen, the inner space of the organ. These signals, combined with antibiotics, help address bacteria that standard treatments cannot reach.
Timeline
2019: Approximately 260,000 deaths occurred due to bacterial antimicrobial resistance in urinary tract infections.
September 2026: Research on the 3D micro-bladder model was published in Nature Communications.
The Tech Race
This development marks a significant shift from static lab cultures to dynamic models that better reflect clinical reality. It aligns with ongoing efforts to improve antibiotic penetration into biofilms, such as the investigation of the therapy CapFuran.
The researchers have made their micro-bladder model and image analysis tools freely available to the global scientific community to accelerate future research. While these findings are currently restricted to a laboratory setting, they provide the necessary framework for testing new treatment protocols for recurrent infections.
The takeaway
The move toward dynamic, physiologically relevant models is essential for solving the problem of intracellular bacterial persistence in urinary tracts. Watch for upcoming results from current clinical trials investigating phage therapy as a viable alternative to failing antibiotic treatments.
Further reading
Learn more about the latest innovations in Life Sciences.
More information
View the complete Nature Communications research article to examine the experimental methodology.
Source note: This article includes information reported by Technology Networks.
Live Poll
Should medical researchers prioritize complex human-relevant models over static lab tests for drug efficacy?
